Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
+44 28 3718 0055Journal of Genetic Disorders & Genetic ReportsISSN: 2327-5790
Baek WS Author
Subjects of specialization
Affiliation
SMS; RAI1; ADHD;; ,Vanderbilt ADHD parent rating scale, Amphetamine-dextroamphetamine, CSHQ;,Ramelteon;
MD,Parkside Medical Group, 1310 San Bernardino Rd, Suite 102, Upland, CA 91786, USA
Biography
Im baek MD,Parkside Medical Group, 1310 San Bernardino Rd, Suite 102, Upland, CA 91786, USA,MD,Parkside Medical Group, 1310 San Bernardino Rd, Suite 102, Upland, CA 91786, USA,MD,Parkside Medical Group, 1310 San Bernardino Rd, Suite 102, Upland, CA 91786, USA
Publications
Case Report Subscription
Smith-Magenis Syndrome Treated with Ramelteon and Amphetamine-dextroamphetamine: Case Report and Review of the Literature
Author(s):
Baek WS, Elsea SH
Objective: Smith-Magenis syndrome (SMS) is a monogenetic disorder caused by haploinsufficiency of the retinoic acid-induced 1 (RAI1) gene on 17p11.2. SMS patients are dysmorphic with developmental delay, autism, attention-deficit hyperactivity disorder (ADHD), and insomnia. Treating the insomnia, ADHD, and disruptive behavior are key in managing SMS; however, to date there are no treatment guidelines or FDA-approved medications.
Methods: We present a case of a 7-year-old girl with developmental delay, insomnia, and behavioral problems whom we had diagnosed with SMS, and treated her insomnia and ADHD.
Results: Ramelteon 4 mg at night decreased her CSHQ (Children Sleep... view more»
Social Media
Google Scholars / Researchers Sites
